Skip to content

iPrime Viscodelivery System

by Glaukos

510(k) K212797

iPrime Viscodelivery System is a medical device (FDA Class II; FDA product code MRH, Pump, Infusion, Ophthalmic) made by Glaukos, cleared under FDA 510(k) K212797 on 6 Jan 2022, active as of 10 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 10 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 10 Oct 2026.

Regulatory status

as of registry sync 10 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK212797 Date6 Jan 2022ClearedStatusActive

Official records

From the FDA record

Received by the FDA
2 Sep 2021
FDA decision
6 Jan 2022 (Substantially Equivalent)
FDA review time
126 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K212797 (openFDA), as read on 10 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MRH
Device class
Class II
Regulation
21 CFR Part 880.5725
Advisory committee
General Hospital
FDA decision
SESE Substantially Equivalent

Devices cleared under K212797

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K212797
UDI-DISize and differences
iPRIME VCP100
GLAUKOS CORPORATION
VCP100 / VCP10000853704002456 —No longer on the market

Similar devices

Other devices filed under FDA product code MRH (Pump, Infusion, Ophthalmic).

Other devices from Glaukos Corporation

See all devices from Glaukos Corporation →